On the public citation graph
Non‐invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE
Inferred edges come from two machine sources: sweeps of open repository
metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is
labelled with the one it came from. Neither is a complete citation index — absence here is not
evidence of absence.
1 of the 63 references listed on this page is in the Retraction Watch database as retracted (export 2026-11-18): 10.1210/jc.2014-2739 (notice 2015-05-01).
Dataset join, best-effort; this page does not check the publisher record.
Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0);
dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated
CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/hep.25731openalex-snapshotEffect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: A randomized controlled trial
inferredcites →https://doi.org/10.1002/hep.25762openalex-snapshotThe diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
inferredcites →https://doi.org/10.1002/hep.26072openalex-snapshotHepatic fat loss in advanced nonalcoholic steatohepatitis: Are alterations in serum adiponectin the cause?
inferredcites →https://doi.org/10.1002/hep.26455openalex-snapshotUtility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials
inferredcites →https://doi.org/10.1002/hep.27014openalex-snapshotOpposite association between diabetes, dyslipidemia, and hepatocellular carcinoma mortality in the middle-aged and elderly
inferredcites →https://doi.org/10.1002/hep.27362openalex-snapshotMagnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study
inferredcites →https://doi.org/10.1002/hep.27647openalex-snapshotEzetimibe for the treatment of nonalcoholic steatohepatitis: Assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)
inferredcites →https://doi.org/10.1002/jmri.24284openalex-snapshotInter-examination precision of magnitude-based MRI for estimation of segmental hepatic proton density fat fraction in obese subjects
inferredcites →https://doi.org/10.1002/jmri.24321openalex-snapshotSpatial distribution of MRI-determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1007/s00330-010-1905-5openalex-snapshotThe diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis
inferredcites →https://doi.org/10.1016/j.cgh.2014.04.014openalex-snapshotFibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
inferredcites →https://doi.org/10.1016/j.cgh.2014.11.027openalex-snapshotNoninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique
inferredcites →https://doi.org/10.1038/ajg.2010.18openalex-snapshotNonalcoholic Fatty Liver Disease Increases Risk of Death Among Patients With Diabetes: A Community-Based Cohort Study
inferredcites →https://doi.org/10.1053/j.gastro.2010.09.038openalex-snapshotPrevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
inferredcites →https://doi.org/10.1093/aje/kws448openalex-snapshotPrevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994
inferredcites →https://doi.org/10.1111/apt.12084openalex-snapshotReview article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non‐alcoholic fatty liver disease
inferredcites →https://doi.org/10.1111/apt.12569openalex-snapshotSystematic review with meta‐analysis: non‐invasive assessment of non‐alcoholic fatty liver disease – the role of transient elastography and plasma cytokeratin‐18 fragments
inferredcites →https://doi.org/10.1111/apt.12963openalex-snapshotPerformance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1111/apt.13196openalex-snapshotComparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non‐invasive diagnosis of advanced fibrosis in biopsy‐proven non‐alcoholic fatty liver disease: a prospective study
inferredcites →https://doi.org/10.1111/apt.13292openalex-snapshotNovel association between serum pentraxin‐2 levels and advanced fibrosis in well‐characterised patients with non‐alcoholic fatty liver disease
inferredcites →https://doi.org/10.1111/j.1365-2036.2012.05121.xopenalex-snapshotCorrelation between liver histology and novel magnetic resonance imaging in adult patients with non‐alcoholic fatty liver disease – MRI accurately quantifies hepatic steatosis in NAFLD
inferredcites →https://doi.org/10.1148/radiol.10100708openalex-snapshotQuantification of Hepatic Steatosis with T1-independent, T2*-corrected MR Imaging with Spectral Modeling of Fat: Blinded Comparison with MR Spectroscopy
inferredcites →https://doi.org/10.1148/radiol.14140754openalex-snapshotAccuracy of MR Imaging–estimated Proton Density Fat Fraction for Classification of Dichotomized Histologic Steatosis Grades in Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1148/radiol.2511080666openalex-snapshotNonalcoholic Fatty Liver Disease: Diagnostic and Fat-Grading Accuracy of Low-Flip-Angle Multiecho Gradient-Recalled-Echo MR Imaging at 1.5 T
inferredcites →https://doi.org/10.1210/jc.2014-2739openalex-snapshotWITHDRAWN: High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels (article published in final form as 10.1210/jc.2015-1966)
inferredcites →https://doi.org/10.1210/jc.2015-1966openalex-snapshotHigh Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
inferredcites →https://doi.org/10.2337/dc06-2247openalex-snapshotPrevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients
inferredcites →https://doi.org/10.2337/dc10-2229openalex-snapshotPrevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study
inferredcites →https://doi.org/10.2337/dc11-0174openalex-snapshotComment on: American Diabetes Association. Standards of Medical Care in Diabetes—2011. Diabetes Care 2011;34(Suppl. 1):S11–S61
inferredcites →https://doi.org/10.2337/dc14-1239openalex-snapshotClinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
inferredcites →https://doi.org/10.3109/07853890.2010.518623openalex-snapshotMeta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4193358openalex-extractedAn Assessment of Atherosclerotic Cardiovascular Disease in Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus
inferred← citeshttps://doi.org/10.1002/hep.28337openalex-snapshotMagnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy‐proven nonalcoholic fatty liver disease: A prospective study
inferred← citeshttps://doi.org/10.1002/hep.29085openalex-snapshotIncreased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
inferred← citeshttps://doi.org/10.1002/hep.29639openalex-snapshotOptimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosis
inferred← citeshttps://doi.org/10.1002/hep.30974openalex-snapshotClinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1002/hep.32244openalex-snapshotEffect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1002/hep4.1603openalex-snapshotElevated Glycated Hemoglobin Is Associated With Liver Fibrosis, as Assessed by Elastography, in a Population‐Based Study of Mexican Americans
inferred← citeshttps://doi.org/10.1002/mrm.70057openalex-snapshotLiver fat quantification at 0. 55 T enabled by locally low‐rank enforced deep learning reconstruction
inferred← citeshttps://doi.org/10.1002/oby.23263openalex-snapshotType 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1002/oby.24130openalex-snapshotObesity increases the risk of hepatic fibrosis in young adults with type 2 diabetes mellitus: the need to screen
inferred← citeshttps://doi.org/10.1007/s00261-026-05449-6openalex-snapshotMRI-derived visceral adipose tissue quantification enhances stratification of nonalcoholic steatohepatitis severity and fibrosis in obesity
inferred← citeshttps://doi.org/10.1007/s00330-017-5075-6openalex-snapshotIncreased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study
inferred← citeshttps://doi.org/10.1007/s00330-021-08381-zopenalex-snapshotMR elastography in nonalcoholic fatty liver disease: inter-center and inter-analysis-method measurement reproducibility and accuracy at 3T
inferred← citeshttps://doi.org/10.1007/s12325-020-01503-xopenalex-snapshotClinical Characteristics of a Non-Alcoholic Fatty Liver Disease Population Across the Fibrosis Spectrum Measured by Magnetic Resonance Elastography: Analysis of Screening Data
inferred← citeshttps://doi.org/10.1016/j.cgh.2019.11.060openalex-snapshotProspective, Same-Day, Direct Comparison of Controlled Attenuation Parameter With the M vs the XL Probe in Patients With Nonalcoholic Fatty Liver Disease, Using Magnetic Resonance Imaging–Proton Density Fat Fraction as the Standard
inferred← citeshttps://doi.org/10.1016/j.cgh.2021.09.041openalex-snapshotClinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis
inferred← citeshttps://doi.org/10.1016/j.clnesp.2025.08.016openalex-snapshotThe diagnostic value of controlled attenuation parameter (CAP) and magnetic resonance imaging derived proton density fat fraction (MRI-PDFF) for the evaluation of intestinal failure-associated liver steatosis among adult chronic intestinal failure patients
inferred← citeshttps://doi.org/10.1016/j.diabet.2019.11.004openalex-snapshotScreening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes
inferred← citeshttps://doi.org/10.1016/j.diabres.2022.109208openalex-snapshotLong-term effects of the changes in hepatic steatosis status on the risk of incident type 2 diabetes mellitus: A 15-year community-based prospective cohort study
inferred← citeshttps://doi.org/10.1016/j.eprac.2022.03.010openalex-snapshotAmerican Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
inferred← citeshttps://doi.org/10.1016/j.gastha.2026.101022openalex-snapshotLongitudinal Validation of Clinical Care Pathways for Metabolic Dysfunction–Associated Steatotic Liver Disease in a Prospective Cohort of Individuals With Type 2 Diabetes
inferred← citeshttps://doi.org/10.1016/j.jhep.2016.06.005openalex-snapshotMRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice
inferred← citeshttps://doi.org/10.1016/j.jhep.2022.11.010openalex-snapshotA prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes
inferred← citeshttps://doi.org/10.1016/s0016-5085(17)30587-5openalex-snapshotMagnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1016/s0168-8278(17)30769-9openalex-snapshotMagnetic resonance elastography vs. transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/s2468-1253(20)30186-2openalex-snapshotNovel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial
inferred← citeshttps://doi.org/10.1038/s41598-025-03528-0openalex-snapshotNonlinear relationship between serum high sensitivity C reactive protein to high density lipoprotein cholesterol ratio with non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1053/j.gastro.2016.10.026openalex-snapshotMagnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1053/j.gastro.2018.04.014openalex-snapshotMagnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1089/met.2021.0098openalex-snapshotPNPLA3 rs 738409 and Other Nongenetic Factors Associated with Hepatic Steatosis Estimated by Magnetic Resonance Imaging Proton Density Fat Fraction in Adult Greek Subjects with Type 2 Diabetes Mellitus
inferred← citeshttps://doi.org/10.1093/cid/ciaa429openalex-snapshotOptimal Threshold of Controlled Attenuation Parameter for Detection of HIV-Associated NAFLD With Magnetic Resonance Imaging as the Reference Standard
inferred← citeshttps://doi.org/10.1093/ndt/gfab266openalex-snapshotPrevalence of non-alcoholic fatty liver disease in patients with chronic kidney disease: a cross-sectional study
inferred← citeshttps://doi.org/10.1097/hep.0000000000000635openalex-snapshotValidation of AGA clinical care pathway and AASLD practice guidance for nonalcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetes
inferred← citeshttps://doi.org/10.1097/meg.0000000000000681openalex-snapshotPrevalence of hepatic steatosis in apparently healthy medical students: a transient elastography study on the basis of a controlled attenuation parameter
inferred← citeshttps://doi.org/10.1111/apt.14327openalex-snapshotSignificant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross‐sectional analysis of 2011‐2014 National Health and Nutrition Examination Survey
inferred← citeshttps://doi.org/10.1111/apt.14463openalex-snapshotObesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis in general practice: a cross‐sectional study using transient elastography
inferred← citeshttps://doi.org/10.1111/apt.14554openalex-snapshotViral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct‐acting anti‐viral therapy
inferred← citeshttps://doi.org/10.1111/apt.15626openalex-snapshotPrevalence of significant hepatic fibrosis using magnetic resonance elastography in a health check‐up clinic population
inferred← citeshttps://doi.org/10.1111/apt.16324openalex-snapshotLiver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non‐alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1111/apt.16350openalex-snapshotEditorial: liver stiffness by magnetic resonance elastography and cardiovascular risk in non‐alcoholic fatty liver disease—simply associated or more complicated?
inferred← citeshttps://doi.org/10.1111/apt.16392openalex-snapshotThe impact of genetic risk on liver fibrosis in non‐alcoholic fatty liver disease as assessed by magnetic resonance elastography
inferred← citeshttps://doi.org/10.1111/apt.17637openalex-snapshotClinical utility of liver fat quantification for determining cardiovascular disease risk among patients with type 2 diabetes
inferred← citeshttps://doi.org/10.1111/apt.17997openalex-snapshotA prospective study on the prevalence of at‐risk MASH in patients with type 2 diabetes mellitus in the United States
inferred← citeshttps://doi.org/10.1111/apt.18377openalex-snapshotA Prospective Study on the Prevalence of MASLD in Patients With Type 2 Diabetes and Hyperferritinaemia
inferred← citeshttps://doi.org/10.1111/dme.13540openalex-snapshotPrevalence and severity of non‐alcoholic fatty liver disease are underestimated in clinical practice: impact of a dedicated screening approach at a large university teaching hospital
inferred← citeshttps://doi.org/10.1111/dme.14356openalex-snapshotMechanisms, screening modalities and treatment options for individuals with non‐alcoholic fatty liver disease and type 2 diabetes
inferred← citeshttps://doi.org/10.1111/dom.12973openalex-snapshotNon‐alcoholic fatty liver disease ( NAFLD ) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes
inferred← citeshttps://doi.org/10.1111/dom.14651openalex-snapshotThe metabolic triad of non‐alcoholic fatty liver disease, visceral adiposity and type 2 diabetes: Implications for treatment
inferred← citeshttps://doi.org/10.1111/liv.13481openalex-snapshotConcomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan
inferred← citeshttps://doi.org/10.1111/liv.13739openalex-snapshotDiabetes impacts prediction of cirrhosis and prognosis by non‐invasive fibrosis models in non‐alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1111/liv.15171openalex-snapshotThe burden of NAFLD in type 2 diabetic subjects from the general population: A Nationwide population‐based follow‐up study ( NASHCO )
inferred← citeshttps://doi.org/10.1111/liv.15259openalex-snapshotPrevalence of advanced hepatic fibrosis and comorbidity in metabolic dysfunction‐associated fatty liver disease in Korea
inferred← citeshttps://doi.org/10.1155/2021/3642463openalex-snapshotProtective Effects of Iridoid Glycoside from Corni Fructus on Type 2 Diabetes with Nonalcoholic Fatty Liver in Mice
inferred← citeshttps://doi.org/10.1155/2022/2760027openalex-snapshotFibrosis‐4 Index Is Closely Associated with Arterial Damage and Future Risk of Coronary Heart Disease in Type 2 Diabetes
inferred← citeshttps://doi.org/10.1172/jci.insight.95354openalex-snapshotTherapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis
inferred← citeshttps://doi.org/10.1177/1756283x16656735openalex-snapshotAssociation of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1177/17562848221093869openalex-snapshotPrognostic utility of magnetic resonance elastography and MEFIB index in predicting liver-related outcomes and mortality in individuals at risk of and with nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1371/journal.pone.0147237openalex-snapshotCost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score
inferred← citeshttps://doi.org/10.1371/journal.pone.0203054openalex-snapshotUtility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial
inferred← citeshttps://doi.org/10.14739/2310-1210.2020.1.194497openalex-snapshotNon-invasive fibrosis markers and elastography in diagnosis of fibrosis severity in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.21037/apm-21-1176openalex-snapshotComparison of magnetic resonance elastography and transient elastography in the diagnosis of hepatic fibrosis: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.21037/atm-20-5216openalex-snapshotClinical implications of serum Mac-2-binding protein glycan isomer as a novel biomarker of advanced hepatic fibrosis in diabetes
inferred← citeshttps://doi.org/10.21037/hbsn-23-563openalex-snapshotAdvancing towards accurate phenotyping based on metabolic and fibrosis risk in metabolic-dysfunction associated steatotic liver disease: one step closer to personalized care
inferred← citeshttps://doi.org/10.2147/ijgm.s460200openalex-snapshotEvaluation of MASLD Fibrosis, FIB-4 and APRI Score in MASLD Combined with T2DM and MACCEs Receiving SGLT2 Inhibitors Treatment
inferred← citeshttps://doi.org/10.2152/jmi.67.280openalex-snapshotLong-term empagliflozin therapy improves levels of hepatic fibrosis marker in patients with non-alcoholic fatty liver disease complicated by type 2 diabetes mellitus
inferred← citeshttps://doi.org/10.2337/cd21-0104openalex-snapshotNoninvasive, Blood-Based Biomarkers as Screening Tools for Hepatic Fibrosis in People With Type 2 Diabetes
inferred← citeshttps://doi.org/10.2337/dc20-1778openalex-snapshotHigh Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes
inferred← citeshttps://doi.org/10.2337/dc20-1997openalex-snapshotAdvanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening
inferred← citeshttps://doi.org/10.25148/etd.fidc009566openalex-snapshotFood Insecurity is Associated with Nonalcoholic Fatty Liver Disease, Cognitive Impairment, and Immune Activation in People Living with HIV
inferred← citeshttps://doi.org/10.26693/jmbs03.05.110openalex-snapshotEndogenous Intoxication Syndrome in Patients with Diabetes Mellitus in Combination with Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.3389/fcvm.2022.991383openalex-snapshotQuantitative MRI in cardiometabolic disease: From conventional cardiac and liver tissue mapping techniques to multi-parametric approaches
inferred← citeshttps://doi.org/10.3390/diagnostics10100809openalex-snapshotClinical and Biochemical Predictors of Nonalcoholic Fatty Liver Disease among Type 2 Diabetes Mellitus Patients at Primary Health Care Level in South Western Saudi Arabia
inferred← citeshttps://doi.org/10.3390/diagnostics11122341openalex-snapshotThe Prevalence of Liver Steatosis and Fibrosis Assessed by Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter in Apparently Healthy Romanian Medical Students
inferred← citeshttps://doi.org/10.3390/healthcare12050591openalex-snapshotInfluence of Sugar-Sweetened Beverages Intake on Sarcopenic Obesity, Visceral Obesity, and Sarcopenia in Lebanese Patients with MASLD: A Case-Control Study
inferred← citeshttps://doi.org/10.3390/ijms222011128openalex-snapshotThe Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.3390/jcm10245755openalex-snapshotLow Screening Rates Despite a High Prevalence of Significant Liver Fibrosis in People with Diabetes from Primary and Secondary Care
inferred← citeshttps://doi.org/10.3410/f.727023474.793574478openalex-snapshotFaculty Opinions recommendation of Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis.
inferred← citeshttps://doi.org/10.3945/jn.116.240358openalex-snapshotIdentification of Potential Plasma Biomarkers for Nonalcoholic Fatty Liver Disease by Integrating Transcriptomics and Proteomics in Laying Hens
inferred← citeshttps://doi.org/10.4093/dmj.2020.0118openalex-snapshotAlbuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.4093/dmj.2022.0381openalex-snapshotAdvanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2022;46:630-9)
inferred← citeshttps://doi.org/10.4137/cmt.s18885openalex-snapshotNonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID:
icsacinstitute.org/submit.